TY - JOUR
T1 - Mutual modulation of femarelle and vitamin D analog activities in human derived female cultured osteoblasts
AU - Somjen, Dalia
AU - Katzburg, Sara
AU - Sharon, O.
AU - Hendel, David
AU - Posner, Gary H.
N1 - Publisher Copyright:
© 2014 Bentham Science Publishers.
PY - 2015/6/1
Y1 - 2015/6/1
N2 - Femarelle (F) activates human derived cultured female bone cells (hObs) and human bone cell line (SaOS2), which express receptors for estradiol-17β (E2; ERα and ERβ) and vitamin D (VDR). Vitamin D metabolites and analogs regulate cell proliferation (DNA) and the specific activity of creatine kinase (CK). Pretreatment with vitamin D less-calcemic analog: JKF 1624F2-2 (JKF) up-regulated responsiveness to estrogens via modulation of ERs mRNA expression. The estrogens in turn induce VDR and 25- hydroxy vitamin D3 1- α hydroxylase (1OHase) expression and 1,25(OH)2D3 (1,25D) synthesis. We compared the effects of F to those of its precourser daidzein (D) and E2 on DNA and CK, and effect of JKF pretreatment. We found: 1. F, D and E2 stimulated DNA and CK. 2. JKF increased ERα and decreased ERβ mRNA expression, up-regulated DNA and CK response to E2 and D but not to F. 3. JKF increased only E2 intracellular competitive binding. 4. F, D and E2 increased VDR and 1OHase mRNA expression and its activity measured by 1,25D production. In conclusion, F, D and E2 increases DNA and CK, as well as 1,25D production and VDR and 1OHase mRNA expression. Pre- treatment with JKF modulates the effect of E2 and D but not of F while all estrogens modulate VDR expression and both mRNA expression and activity of 1OHase in the cells. These finding that F effects are not affected by the vitamin D levels in female-derived osteoblasts may contribute to its beneficial role in treatment of post-menopausal bone loss.
AB - Femarelle (F) activates human derived cultured female bone cells (hObs) and human bone cell line (SaOS2), which express receptors for estradiol-17β (E2; ERα and ERβ) and vitamin D (VDR). Vitamin D metabolites and analogs regulate cell proliferation (DNA) and the specific activity of creatine kinase (CK). Pretreatment with vitamin D less-calcemic analog: JKF 1624F2-2 (JKF) up-regulated responsiveness to estrogens via modulation of ERs mRNA expression. The estrogens in turn induce VDR and 25- hydroxy vitamin D3 1- α hydroxylase (1OHase) expression and 1,25(OH)2D3 (1,25D) synthesis. We compared the effects of F to those of its precourser daidzein (D) and E2 on DNA and CK, and effect of JKF pretreatment. We found: 1. F, D and E2 stimulated DNA and CK. 2. JKF increased ERα and decreased ERβ mRNA expression, up-regulated DNA and CK response to E2 and D but not to F. 3. JKF increased only E2 intracellular competitive binding. 4. F, D and E2 increased VDR and 1OHase mRNA expression and its activity measured by 1,25D production. In conclusion, F, D and E2 increases DNA and CK, as well as 1,25D production and VDR and 1OHase mRNA expression. Pre- treatment with JKF modulates the effect of E2 and D but not of F while all estrogens modulate VDR expression and both mRNA expression and activity of 1OHase in the cells. These finding that F effects are not affected by the vitamin D levels in female-derived osteoblasts may contribute to its beneficial role in treatment of post-menopausal bone loss.
KW - 10 Hase
KW - CK
KW - DNA
KW - ERs
KW - Estrogens
KW - Osteoblasts
KW - VDR
KW - Vitamin D
UR - http://www.scopus.com/inward/record.url?scp=84930520399&partnerID=8YFLogxK
U2 - 10.2174/187152221403150521105814
DO - 10.2174/187152221403150521105814
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:84930520399
VL - 14
SP - 162
EP - 170
JO - Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents
JF - Current Medicinal Chemistry: Immunology, Endocrine and Metabolic Agents
SN - 1871-5222
IS - 3
ER -
